The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
Cummings, S. R., Martin, J. S., McClung, M. R., Siris, E. S., Eastell, R., Reid, I. R., Delmas, P., Zoog, H. B., Austin, M., Wang, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809493 · Cited by 3,489
Self-citationBlack, D. M., Schwartz, A. V., Ensrud, K. E., Cauley, J. A., Levis, S., Quandt, S. A., Satterfield, S., Wallace, R. B., Bauer, D. C., Palermo, L., et al. (2006) · JAMA · doi:10.1001/jama.296.24.2927 · Cited by 1,407
Bisphosphonates: The first 40years
Russell, R. G. G. (2011) · Bone · doi:10.1016/j.bone.2011.04.022 · Cited by 1,124
Bone, H. G., Wagman, R. B., Brandi, M. L., Brown, J. P., Chapurlat, R., Cummings, S. R., Czerwiński, E., Fahrleitner-Pammer, A., Kendler, D. L., Lippuner, K., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30138-9 · Cited by 996
Black, D. M., Reid, I. R., Boonen, S., Bucci-Rechtweg, C., Cauley, J. A., Cosman, F., Cummings, S. R., Hue, T. F., Lippuner, K., Lakatos, P., et al. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1494 · Cited by 700
Self-citationAdler, R. A., El-Hajj Fuleihan, G., Bauer, D. C., Camacho, P. M., Clarke, B. L., Clines, G. A., Compston, J. E., Drake, M. T., Edwards, B. J., Favus, M. J., et al. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2708 · Cited by 672
Bone, H. G., Bolognese, M. A., Yuen, C. K., Kendler, D. L., Miller, P. D., Yang, Y.-C., Grazette, L., San Martin, J., & Gallagher, J. C. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1502 · Cited by 623
Leder, B. Z., Tsai, J. N., Uihlein, A. V., Wallace, P. M., Lee, H., Neer, R. M., & Burnett-Bowie, S.-A. M. (2015) · The Lancet · doi:10.1016/s0140-6736(15)61120-5 · Cited by 603
Miller, P. D., Bolognese, M. A., Lewiecki, E. M., McClung, M. R., Ding, B., Austin, M., Liu, Y., & San Martin, J. (2008) · Bone · doi:10.1016/j.bone.2008.04.007 · Cited by 578
Anastasilakis, A. D., Polyzos, S. A., Makras, P., Aubry‐Rozier, B., Kaouri, S., & Lamy, O. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3110 · Cited by 371
Self-citationCompston, J., Bowring, C., Cooper, A., Cooper, C., Davies, C., Francis, R., Kanis, J. A., Marsh, D., McCloskey, E. V., Reid, D. M., et al. (2013) · Maturitas · doi:10.1016/j.maturitas.2013.05.013 · Cited by 304
on behalf of the DAPS Investigators, Freemantle, N., Satram-Hoang, S., Tang, E.-T., Kaur, P., Macarios, D., Siddhanti, S., Borenstein, J., & Kendler, D. L. (2012) · Osteoporosis International · doi:10.1007/s00198-011-1780-1 · Cited by 288
Observations following discontinuation of long-term denosumab therapy
McClung, M. R., Wagman, R. B., Miller, P. D., Wang, A., & Lewiecki, E. M. (2017) · Osteoporosis International · doi:10.1007/s00198-017-3919-1 · Cited by 227
Prince, R., Sipos, A., Hossain, A., Syversen, U., Ish-Shalom, S., Marcinowska, E., Halse, J., Lindsay, R., Dalsky, G. P., & Mitlak, B. H. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050501 · Cited by 207
Lamy, O., Gonzalez-Rodriguez, E., Stoll, D., Hans, D., & Aubry-Rozier, B. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3170 · Cited by 191
Self-citationCummings, S. R., Cosman, F., Lewiecki, E. M., Schousboe, J. T., Bauer, D. C., Black, D. M., Brown, T. D., Cheung, A. M., Cody, K., Cooper, C., et al. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3039 · Cited by 165
Self-citationPopp, A. W., Zysset, P. K., & Lippuner, K. (2016) · Osteoporosis International · doi:10.1007/s00198-015-3458-6 · Cited by 159
Severe spontaneous vertebral fractures after denosumab discontinuation: three case reports
Aubry‐Rozier, B., Rodríguez, E. G., Stoll, D., & Lamy, O. (2015) · Osteoporosis International · doi:10.1007/s00198-015-3380-y · Cited by 157
Self-citationBrown, J. P., Roux, C., Törring, O., Ho, P., Jensen, J. B., Gilchrist, N. L., Recknor, C. P., Austin, M., Wang, A., Grauer, A., et al. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1808 · Cited by 153
Leder, B. Z., Neer, R. M., Wyland, J. J., Lee, H. W., Burnett‐Bowie, S. M., & Finkelstein, J. S. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2630 · Cited by 143
Miller, P. D., Wagman, R. B., Peacock, M., Lewiecki, E. M., Bolognese, M. A., Weinstein, R. L., Ding, B., Martín, J. S., & McClung, M. R. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1805 · Cited by 141
Anagnostis, P. G., Paschou, S. Α., Mintziori, G., Ceauşu, I., Depypere, H. T., Lambrinoudaki, I. V., Mueck, A. O., Pérez-López, F. R., Rees, M., Senturk, L. M., et al. (2017) · Maturitas · doi:10.1016/j.maturitas.2017.04.008 · Cited by 134
Bone Loss After Denosumab: Only Partial Protection with Zoledronate
Reid, I. R., Horne, A. M., Mihov, B., & Gamble, G. D. (2017) · Calcified Tissue International · doi:10.1007/s00223-017-0288-x · Cited by 119
Leder, B. Z., Tsai, J. N., Jiang, L. A., & Lee, H. (2017) · Bone · doi:10.1016/j.bone.2017.03.006 · Cited by 112
McClung, M. R. (2016) · Osteoporosis International · doi:10.1007/s00198-016-3553-3 · Cited by 107
Multiple clinical vertebral fractures following denosumab discontinuation
Anastasilakis, A. D., & Makras, P. (2015) · Osteoporosis International · doi:10.1007/s00198-015-3459-5 · Cited by 91
Anastasilakis, A. D., Yavropoulou, M. P., Makras, P., Sakellariou, G. T., Papadopoulou, F. G., Gerou, S., & Papapoulos, S. E. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-1027 · Cited by 88
Brown, J. P., Dempster, D. W., Ding, B., Dent-Acosta, R. E., Martín, J. S., Grauer, A., Wagman, R. B., & Zanchetta, J. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.448 · Cited by 87
Uebelhart, B., Rizzoli, R., & Ferrari, S. (2017) · Osteoporosis International · doi:10.1007/s00198-017-4080-6 · Cited by 73
Bisphosphonate binding affinity as assessed by inhibition of carbonated apatite dissolutionin vitro
Henneman, Z. J., Nancollas, G. H., Ebetino, F. H., Russell, R. G. G., & Phipps, R. J. (2007) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31599 · Cited by 64
Possible protective effect of switching from denosumab to zoledronic acid on vertebral fractures
Lehmann, T., & Aeberli, D. (2017) · Osteoporosis International · doi:10.1007/s00198-017-4108-y · Cited by 54
Hypercalcemia after discontinuation of long-term denosumab treatment
Sølling, A. S., Harsløf, T., Kaal, A., Rejnmark, L., & Langdahl, B. L. (2016) · Osteoporosis International · doi:10.1007/s00198-016-3535-5 · Cited by 44
Self-citationClinical vertebral fractures following denosumab discontinuation
Pοlyzos, S. A., & Terpos, E. (2016) · Endocrine · doi:10.1007/s12020-016-1030-6 · Cited by 42
Gossiel, F., Hoyle, C., McCloskey, E. V., Naylor, K. E., Walsh, J., Peel, N. F. A., & Eastell, R. (2016) · Bone · doi:10.1016/j.bone.2016.08.010 · Cited by 39
Self-citationFrequency of discontinuation of injectable osteoporosis therapies in US patients over 2 years
Modi, A., Sajjan, S., Insinga, R. P., Weaver, J. P., Lewiecki, E. M., & Harris, S. T. (2017) · Osteoporosis International · doi:10.1007/s00198-016-3886-y · Cited by 39
The effect of cessation of raloxifene treatment on bone turnover in postmenopausal women
Naylor, K. E., Clowes, J. A., Finigan, J., Paggiosi, M., Peel, N. F. A., & Eastell, R. (2009) · Bone · doi:10.1016/j.bone.2009.10.043 · Cited by 34
Self-citationHow Long to Treat with Denosumab
Costa, A. G., & Bilezikian, J. P. (2015) · Current Osteoporosis Reports · doi:10.1007/s11914-015-0295-7 · Cited by 11
Cited by
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF), Kanis, J. A., Cooper, C., Rizzoli, R., & Reginster, J.-Y. (2019) · Osteoporosis International · doi:10.1007/s00198-018-4704-5 · Cited by 1,900
The clinician's guide to prevention and treatment of osteoporosis
LeBoff, M. S., Greenspan, S. L., Insogna, K. L., Lewiecki, E. M., Saag, K. G., Singer, A. J., & Siris, E. S. (2022) · Osteoporosis International · doi:10.1007/s00198-021-05900-y · Cited by 1,487
Ruggiero, S. L., Dodson, T. B., Aghaloo, T., Carlson, E. R., Ward, B. B., & Kademani, D. (2022) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2022.02.008 · Cited by 1,141
Eastell, R., Rosen, C. J., Black, D. M., Cheung, A. M., Murad, M. H., & Shoback, D. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00221 · Cited by 868
Self-citationJohnston, C. B., & Dagar, M. (2020) · Medical Clinics of North America · doi:10.1016/j.mcna.2020.06.004 · Cited by 615
Metadata
- Authors
- Tsourdi, E., Langdahl, B., Cohen-Solal, M., Aubry-Rozier, B., Eriksen, E. F., Guañabens, N., Obermayer-Pietsch, B., Ralston, S. H., Eastell, R., & Zillikens, M. C.
- Venue
- Bone
- Publisher
- Elsevier BV
- Published
- 2017-12
- Volume
- 105
- Pages
- 11-17
- ISSN
- 1873-2763 (ISSN-L)
- 8756-3282
- OpenAlex
- W2743295977
- Cited by
- 504
- References
- 37
- FWCI
- 10.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.